Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics today reported an 8 percent year over year increase in revenues for the second quarter.

For the three months ended June 30, the molecular diagnostics and pathology services firm posted $3.9 million in revenues, up from $3.6 million in the year-ago period.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.